What’s Next for Peptides? Regulation, Compounding & More | Jim Lavalle
EP. 279: Join my NEW community for Gen X women: https://www.skool.com/drtyna/about
A major hearing on peptides just happened in Washington, and it could reshape access for patients and practitioners alike. I'm joined by Jim LaValle, chair of the International Peptide Society, who was in the room for the FDA's compounding advisory committee meeting. We talk about what actually went down behind the scenes, why most of the compounds under review got the green light to move toward broader legal access, the gray market crisis putting patients at risk, and what it all means for the future of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.